Food News and Research

RSS

FDA approves InVivo Therapeutics' IDE to test biopolymer scaffold product in humans

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the U.S. Food and Drug Administration has approved the Company's Investigational Device Exemption to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.

5 Apr 2013

Global interconnectedness influences population health

In a global health review article in the New England Journal of Medicine, Anthony McMichael of the National Centre for Epidemiology and Population Health at the Australian National University examines the effects of globalization and "international connectivity" on "human health, international health care, and public health activities."

5 Apr 2013

Non-invasive gut health testing breakthrough

Health and functional claims made for foods such as probiotics still need to prove their effectiveness ― an important part of the answer rests in our small intestines and their role in digestion, and immunity.

5 Apr 2013

UIC College of Pharmacy receives grant to train students in natural product drugs

Elizabeth Martinez hopes to one day discover a cure for menopausal symptoms using an herbal dietary supplement. With the help of a new federal training grant to the University of Illinois at Chicago College of Pharmacy, her vision may become reality.

5 Apr 2013

SLU student aims to improve easy access to fresh, healthy food by creating mobile farmer's market

When the State of Texas decided to slash tuition grants for private schools, Goss lobbied against the measure, saving his university from a steep cut. After living in St. Louis for two years, the second-year medical student at Saint Louis University has decided to tackle another problem - food deserts.

5 Apr 2013

Research findings provide insight into severe bacterial infectious diseases

UT Southwestern Medical Center researchers report that a pathogen annually blamed for an estimated 90 million cases of food-borne illness defeats a host's immune response by using a fat-snipping enzyme to cut off cellular communication.

5 Apr 2013

FDA approves CryoLife's next generation HeRO device

CryoLife, Inc., a leading tissue processing and medical device company focused on cardiac and vascular surgery, announced today that it has received U.S. Food and Drug Administration 510(k) clearance for a next generation HeRO (Hemodialysis Reliable Outflow) device.

5 Apr 2013

Banning trans fat may prevent some of the world’s biggest killer diseases

Banning the use of trans fats in the preparation of foodstuffs is one of the most effective ways to prevent some of the world’s biggest killer diseases, but many governments are not taking such action because they do not think these bans work, according to a University of Sydney study published in the Bulletin of the World Health Organization today.

4 Apr 2013

InVivo Therapeutics obtains HUD designation from FDA for spinal cord injury treatment

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that the Company has received approval for its request filed with the U.S. Food and Drug Administration for Humanitarian Use Device designation for its biopolymer scaffolding product.

4 Apr 2013

Phenylbutazone in horsemeat detected by Thermo Fisher Scientific test

Thermo Fisher Scientific Inc., the world leader in serving science, recently mobilized its Food Safety Response Center (FSRC) to develop a method to test for the presence of the veterinary drug phenylbutazone in horsemeat. Phenylbutazone, also known as “bute,” is a potent painkiller banned in any horsemeat intended for human consumption.

From Thermo Fisher Scientific Inc. 4 Apr 2013

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.

4 Apr 2013

More flexible food aid plan would allow better use of taxpayer dollars

"When it comes to providing hunger relief to needy people around the world, the United States has been a leader since World War II. And if early reports about the Obama administration's 2014 budget are true, then the U.S. will have a golden opportunity to provide even more food to the hungry while spending less taxpayer dollars in the years ahead," Catherine Bertini and Dan Glickman, co-chairs of the Chicago Council on Global Affairs' Global Agricultural Development Initiative, write in a Politico opinion piece.

4 Apr 2013

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

President Obama officially announced his new brain research initiative on Tuesday, with a pledge to put $100 million in his 2014 budget to support work at three federal agencies.

4 Apr 2013

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food and Drug Administration has approved its New Drug Application for Karbinal ER (carbinoxamine maleate) Extended-release Oral Suspension 4mg/5ml, the first sustained-release histamine receptor blocking agent indicated for the treatment of seasonal and perennial allergic rhinitis in children ages 2 and up.

4 Apr 2013

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Acyclovir Ointment USP, 5%.

4 Apr 2013

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

ERYTECH Pharma SA announced today that it has received clearance of its Investigational New Drug Application from the United States Food and Drug Administration to initiate a Phase I clinical trial of its product ERYASP, L-asparaginase loaded erythrocytes, in patients 40 years or older with newly diagnosed Acute Lymphoblastic Leukemia.

4 Apr 2013

New biochemical evidence shows cereal grain sorghum safe food for people with celiac disease

Strong new biochemical evidence exists showing that the cereal grain sorghum is a safe food for people with celiac disease, who must avoid wheat and certain other grains, scientists are reporting.

4 Apr 2013

Study shows relationship between cocaine-induced brain deficits in prefrontal cortex and cocaine-seeking

Could drug addiction treatment of the future be as simple as an on/off switch in the brain? A study in rats has found that stimulating a key part of the brain reduces compulsive cocaine-seeking and suggests the possibility of changing addictive behavior generally.

4 Apr 2013

A new method to kill pathogenic bacteria

Engineering researchers at Rensselaer Polytechnic Institute have developed a new method to kill deadly pathogenic bacteria, including listeria, in food handling and packaging. This innovation represents an alternative to the use of antibiotics or chemical decontamination in food supply systems.

3 Apr 2013

New medical device detects biothreat agents

Researchers at Sandia National Laboratories are developing a medical instrument that will be able to quickly detect a suite of biothreat agents, including anthrax, ricin, botulinum, shiga and SEB toxin.

3 Apr 2013

Food News and Research

FDA approves InVivo Therapeutics' IDE to test biopolymer scaffold product in humans

Global interconnectedness influences population health

Non-invasive gut health testing breakthrough

UIC College of Pharmacy receives grant to train students in natural product drugs

SLU student aims to improve easy access to fresh, healthy food by creating mobile farmer's market

Research findings provide insight into severe bacterial infectious diseases

FDA approves CryoLife's next generation HeRO device

Banning trans fat may prevent some of the world’s biggest killer diseases

InVivo Therapeutics obtains HUD designation from FDA for spinal cord injury treatment

Phenylbutazone in horsemeat detected by Thermo Fisher Scientific test

Noven Pharmaceuticals files ANDA with FDA for approval of generic version of Exelon

More flexible food aid plan would allow better use of taxpayer dollars

Viewpoints: Obama's brain initiative is 'modest but welcome start;' Disability insurance facing 'immediate crisis'

Tris Pharma gets FDA NDA approval for Karbinal ER Extended-release Oral Suspension

FDA approves Mylan's ANDA for generic version of Zovirax Ointment

FDA clears ERYTECH Pharma' IND to start Phase I clinical trial of ERYASP in patients with ALL

New biochemical evidence shows cereal grain sorghum safe food for people with celiac disease

Study shows relationship between cocaine-induced brain deficits in prefrontal cortex and cocaine-seeking

A new method to kill pathogenic bacteria

New medical device detects biothreat agents

Enhancing confidence in chemical ionization spectrometry data eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News